Ionis Pharmaceuticals, Inc.
Compositions and methods for modulating growth hormone receptor expression
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions for treating, preventing, or ameliorating a disease associated with excess growth hormone using antisense compounds or oligonucleotides targeted to growth hormone receptor (GHR).
Status:
Grant
Type:
Utility
Filling date:
4 Aug 2020
Issue date:
26 Apr 2022